Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
482
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Access at the doorstep: Supporting engagement with movement-based programmes.

Social science & medicine (1982)·2026
Same author

The Progressive Aphasia Communication Toolkit (PACT): a strengths-based approach to multidomain evaluation for intervention.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Familial involvement in infant cares in the setting of language discordant nurse-family pairings.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

STELLA-FTD: Examination of a Behavior Change Intervention for Frontotemporal Dementia Family Care Partners.

Alzheimer's & dementia. Behavior & socioeconomics of aging·2026
Same author

Dementia diagnosis in primary care: testing an educational program in Oregon.

Gerontology & geriatrics education·2025
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K

Technology and Dementia Preconference.

Allison Lindauer1,2, Aimee R Mooney1,2, Christina S Zonker1,2

  • 1Oregon Health & Science University, Portland, OR, USA.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 23, 2025
PubMed
Summary
This summary is machine-generated.

Caregiver withdrawal from dementia intervention studies is often due to care recipient death or overwhelming responsibilities, not demographics or dissatisfaction. Understanding these reasons helps support families caring for loved ones with dementia.

More Related Videos

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

Related Experiment Videos

Last Updated: Jan 8, 2026

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
07:31

A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills

Published on: February 13, 2020

7.3K
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
08:36

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Published on: July 28, 2022

4.3K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

2.0K

Area of Science:

  • Gerontology
  • Dementia Care
  • Behavioral Interventions

Background:

  • Limited literature exists on caregiver withdrawal from behavioral interventions for dementia.
  • This study examines withdrawal from the Tele-STELLA telehealth intervention for dementia caregivers.
  • Tele-STELLA provided strategies to manage distressing behavioral symptoms in dementia.

Purpose of the Study:

  • To identify characteristics and reasons for caregiver withdrawal from the Tele-STELLA intervention.
  • To compare withdrawn caregivers with those who completed the study.
  • To inform future dementia caregiver support strategies.

Main Methods:

  • Compared withdrawn caregivers to non-withdrawn caregivers on demographics, dementia characteristics, and study-related variables.
  • Utilized chi-squared tests for categorical data and t-tests/ANOVA for continuous data.
  • Statistical significance was determined by p-values less than 0.05.

Main Results:

  • 30.3% of caregivers (n=57) withdrew from Tele-STELLA.
  • Severe dementia in care recipients and care recipient death were significantly associated with withdrawal.
  • Overwhelming responsibilities were a primary reason for withdrawal, especially during the active intervention phase.
  • Withdrawal timing correlated with adverse events; those withdrawing later experienced more adverse events.
  • Demographics, burden, and study satisfaction were not linked to withdrawal.

Conclusions:

  • Family caregivers enroll in interventions even late in the dementia journey, indicating a need for support.
  • Caregiver withdrawal is primarily driven by care recipient death or adverse events, not personal factors like burden or dissatisfaction.
  • Data from caregivers in later stages of dementia is crucial for understanding their experiences and support needs.
  • Future research should account for higher withdrawal rates in planning and analysis.